Alex Zhavoronkov
Founder of Insilico Medicine, developer of the AI-designed drug rentoceratib
Alex Zhavoronkov (Founder of Insilico Medicine, developer of the AI-designed drug rentoceratib) is discussed on podcasts in TMT.
Discussed in
Should we slow down AI progress? | MOONSHOTS #288Moonshots with Peter Diamandis · Sep 11, 2026 · 2 h 44 min
The Moonshots panel and Emad Mostaque debate AI safety resignations, P(doom), the Navier-Stokes solution, data as moat, GPU economics and AI-designed longevity drugs.